Filing Details
- Accession Number:
- 0001628280-24-010352
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-11 21:22:52
- Reporting Period:
- 2024-03-07
- Accepted Time:
- 2024-03-11 21:22:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1671284 | Neuehealth Inc. | NEUE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1381037 | Iii Lawrence George Mikan | C/O Neuehealth, Inc. 8000 Norman Center Drive, Suite 900 Minneapolis MN 55437 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-07 | 7,565 | $0.00 | 96,369 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-07 | 7,886 | $9.88 | 88,483 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-08 | 5,096 | $8.42 | 83,387 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2024-03-07 | 7,565 | $0.00 | 7,565 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,565 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.32 to $11.05 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $9.30 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- These restricted stock units vest in three equal annual installments beginning on March 7, 2023.
Billionaire Hedge Funds
